Summary: In an article covering unique and innovative approaches to funding psychedelic research, Bloomberg highlights the perspective shared by MAPS Public Benefit Corporation (MAPS PBC) CEO Amy Emerson …
Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once …
In an op-ed published by The Guardian, MAPS Founder Rick Doblin, Ph.D., explores how advancing scientific understanding of psychedelic therapies offers hope for achieving mass mental health. Doblin illustrates …
In the Netherlands there are almost 150,000 people who suffer from post-traumatic stress disorder (PTSD). They have experienced something so intense that it left them traumatized. As a result, they suffer …
Summary: In a new episode of the Shrink Speak Podcast, Dr. Jeffrey Lieberman speaks with MAPS Founder Rick Doblin, Ph.D., and Dr. Steven Levine to explore recent progress in psychedelic research, therapeutic …
CBS News airs an investigative report about treating PTSD with MDMA-assisted therapy on a new episode of CBS Sunday Morning. In a series of interviews with David Martin of CBS, former Marine Scott Ostrom …
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
MAPS is on The TODAY Show! This morning, NBC educated millions of people about psychedelic science by airing an interview with MAPS Founder Rick Doblin, Ph.D., and MDMA-assisted therapy study participants …
Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted …
We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. We’ve already accrued about 57 of the 100 subjects needed so potential volunteers …
Summary: Verywell Health explores the potential impact that psychedelics could have on healing trauma caused by the COVID-19 pandemic in an interview with MAPS Founder Rick Doblin, Ph.D. “Doblin …
